Brainlab AG announced a strategic collaboration with Boston Scientific Corporation, a leading innovator of medical solutions that improve the health of patients around the world.
Boston Scientific will begin distributing the Brainlab DBS surgical planning portfolio with the Boston Scientific Vercise™ DBS System in selected countries, offering physicians advanced device technology with sophisticated software capabilities.
The collaboration provides patients and physicians a comprehensive portfolio for Deep Brain Stimulation (DBS) therapy. DBS therapy is intended to treat a variety of disorders, including Parkinson’s disease.
By streamlining DBS treatments, Brainlab and Boston Scientific anticipate our joint solutions will serve as a future platform to further increase the access to and consistency of care.
Find out more here.
X
This website uses cookies
We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.
